The Valley Desk

NCT07448610 · Interventional trial

ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)

Overall registry status Recruiting

Phase 4

Conditions Spinal Muscular Atrophy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov